Advancements in HIV/AIDS Treatment and Prevention

Since its emergence in the early 1980s, HIV/AIDS has posed a formidable global health challenge, affected millions of lives and prompted an urgent response from the scientific and medical communities. Over the past few decades, significant advancements have transformed the landscape of HIV/AIDS treatment and prevention. Antiretroviral therapy (ART) has been pivotal, evolving from early monotherapy to modern combination regimens that significantly improved the quality of life and life expectancy for those living with HIV. The development of long-acting antiretrovirals further enhances adherence and convenience for patients. On the prevention front, preexposure prophylaxis (PrEP) has emerged as a highly effective strategy, reducing the risk of infection among high-risk populations. Advances in vaccine research and immune-based therapies offer hope for future prevention and potential cures. Despite these achievements, challenges such as ensuring equitable access to treatment, addressing drug resistance, and overcoming stigma and discrimination persist. This review explored the latest developments in ART and preventive measures, using a comprehensive literature review methodology, and highlights ongoing efforts to address global disparities in access and care. Continued investment in research, healthcare infrastructure, and community engagement is crucial for sustaining progress and ultimately ending the HIV/AIDS epidemic. Keywords: Antiretroviral Therapy (ART), Pre-Exposure Prophylaxis (PrEP), HIV/AIDS Prevention, Long Acting Antiretrovirals, HIV Vaccine Development